Infectious disease epidemiologist and a professor of epidemiology at Emory University's Rollins School of Public Health in Atlanta
US Shouldn't Back Out of Funding HIV Research After Huge Strides Made: Patrick Sullivan, DVM, PhD
The government should focus on keeping up the funding for HIV to continue to innovate in this space, potentially eliminating the virus altogether.
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
Funding cuts for research intended to make treatment and cures available and accessible for patients with HIV could affect HIV care in the long term.
Reductions in Funding for HIV Prevention Services Could Jeopardize Epidemic Control: Patrick Sullivan, DVM, PhD
Several actions taken by the current administration may affect the landscape of prevention of HIV, prompting an analysis of these effects.
Rolling Back PrEP Coverage Affects Both New Infections, Economic Cost: Patrick Sullivan, DVM, PhD
Any potential reduction in access to pre-exposure prophylaxis (PrEP) would increase both cost and the number of diagnoses of HIV.